» Articles » PMID: 28509301

AP-VAS 2012 Case Report: Anti-glomerular Basement Membrane Disease with High Titer of Myeloperoxidase Anti-neutrophil Cytoplasmic Antibody-an Autopsy Case Report

Overview
Journal CEN Case Rep
Specialty Nephrology
Date 2017 May 17
PMID 28509301
Authors
Affiliations
Soon will be listed here.
Abstract

It has been reported that patients who are positive for both myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane (GBM) antibody have a poor prognosis. We present an autopsy case of anti-GBM disease with a high titer of MPO-ANCA. The patient was a 77-year-old woman with a medical history of idiopathic interstitial pneumonia. After being treated for bacterial pneumonia, she was referred to our hospital for evaluation of non-nephrotic range proteinuria, hematuria, and a course of rapidly progressive glomerulonephritis. Results of urinalysis were 2+ for protein and 3+ for blood, with many dysmorphic red blood cells observed in the urinary sediment. A sample of a 24-h urine collection contained 0.3 g protein. The serum creatinine concentration was 5.0 mg/dl on admission. The patient tested positive for MPO-ANCA at a titer of >640 EU and for anti-GBM antibody at a titer of 14 EU. Renal biopsy revealed glomerulonephritis with crescent formation, and immunofluorescence studies showed that the glomeruli had a generalized linear fluorescence and anti-immunoglobulin G (IgG) and C along the peripheral glomerular capillaries. She was diagnosed with anti-GBM disease. Treatment was started with intravenous prednisolone and oral cyclophosphamide, followed by plasma exchange. Despite improved renal function, she died of pulmonary hemorrhage. Autopsy revealed deposits of IgG and C in the basement membranes of lung alveoli.

References
1.
Hellmark T, Johansson C, Wieslander J . Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int. 1994; 46(3):823-9. DOI: 10.1038/ki.1994.338. View

2.
Cui Z, Zhao J, Jia X, Zhu S, Jin Q, Cheng X . Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study. Medicine (Baltimore). 2011; 90(5):303-311. DOI: 10.1097/MD.0b013e31822f6f68. View

3.
Bosch X, Mirapeix E, Font J, Borrellas X, Rodriguez R, Lopez-Soto A . Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol. 1991; 36(3):107-13. View

4.
Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Cohen Tervaert J . Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis. 2005; 46(2):253-62. DOI: 10.1053/j.ajkd.2005.05.003. View

5.
Papiris S, Manali E, Kalomenidis I, Kapotsis G, Karakatsani A, Roussos C . Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist. Crit Care. 2007; 11(3):213. PMC: 2206392. DOI: 10.1186/cc5778. View